These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
187 related items for PubMed ID: 1802680
21. Gonadotropin-releasing hormone regulates gonadotropin beta-subunit and chromogranin-B messenger ribonucleic acids in cultured chromogranin-A-positive pituitary adenomas. Song JY, Jin L, Chandler WF, England BG, Smart JB, Landefeld TD, Lloyd RV. J Clin Endocrinol Metab; 1990 Sep; 71(3):622-30. PubMed ID: 2118538 [Abstract] [Full Text] [Related]
22. The effect of thyrotropin-releasing hormone on gonadotropin and free alpha-subunit secretion in patients with acromegaly and functionless pituitary tumors. Popovic V, Damjanovic S. Thyroid; 1998 Oct; 8(10):935-9. PubMed ID: 9827662 [Abstract] [Full Text] [Related]
23. Secretion of LH, FSH, and PRL shown by cell culture and immunocytochemistry of human functionless pituitary adenomas. Mashiter K, Adams E, Van Noorden S. Clin Endocrinol (Oxf); 1981 Aug; 15(2):103-12. PubMed ID: 6796297 [Abstract] [Full Text] [Related]
24. Gonadotropin-secreting pituitary adenoma with concomitant hypersecretion of testosterone and elevated sperm count. Treatment with LRH agonist. Zárate A, Fonseca ME, Mason M, Tapia R, Miranda R, Kovacs K, Schally AV. Acta Endocrinol (Copenh); 1986 Sep; 113(1):29-34. PubMed ID: 2945349 [Abstract] [Full Text] [Related]
25. Blood serum concentrations of gonadotropins and α-subunit in patients with gonadotropinomas in relation to the immunoreactivity of pituitary adenoma. Pawlikowski Łódź M, Jaranowska M, Fryczak J, Radek M, Świętosławski J, Kunert-Radek J, Winczyk K. Endokrynol Pol; 2018 Sep; 69(5):526-529. PubMed ID: 30074232 [Abstract] [Full Text] [Related]
26. Gonadotroph adenomas in men produce biologically active follicle-stimulating hormone. Galway AB, Hsueh AJ, Daneshdoost L, Zhou MH, Pavlou SN, Snyder PJ. J Clin Endocrinol Metab; 1990 Oct; 71(4):907-12. PubMed ID: 2119391 [Abstract] [Full Text] [Related]
27. Central hypogonadism due to a giant, "silent" FSH-secreting, atypical pituitary adenoma: effects of adenoma dissection and short-term Leydig cell stimulation by luteinizing hormone (LH) and human chorionic gonadotropin (hCG). Santi D, Spaggiari G, Casarini L, Fanelli F, Mezzullo M, Pagotto U, Granata ARM, Carani C, Simoni M. Aging Male; 2017 Jun; 20(2):96-101. PubMed ID: 28067604 [Abstract] [Full Text] [Related]
28. Differing responses of plasma bioactive and immunoreactive follicle-stimulating hormone and luteinizing hormone to gonadotropin-releasing hormone antagonist and agonist treatments in postmenopausal women. Matikainen T, Ding YQ, Vergara M, Huhtaniemi I, Couzinet B, Schaison G. J Clin Endocrinol Metab; 1992 Sep; 75(3):820-5. PubMed ID: 1517372 [Abstract] [Full Text] [Related]
33. Partial hypopituitarism and hyperprolactinemia: successful induction of ovulation with bromocriptine and human menopausal gonadotropins. Dawood MY, Jarrett JC, Choe JK. Fertil Steril; 1982 Oct; 38(4):415-8. PubMed ID: 6811337 [Abstract] [Full Text] [Related]
34. Confounding factors in the interpretation of gonadotropin and gonadotropin-subunit release from cultured human pituitary adenomas. Kwekkeboom DJ, de Jong FH, Lamberts SW. J Steroid Biochem; 1989 Oct; 33(4B):777-82. PubMed ID: 2513452 [Abstract] [Full Text] [Related]